Walleye Capital
HAE icon

Walleye Capital’s Haemonetics HAE Stock Holding History

Walleye Capital’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-66,359
Closed -$3.74M – 4902
2026
Q1 		$3.74M Buy
66,359
+6,411
+11% +$418K 0.02% 994
2025
Q4 		$4.8M Sell
59,948
-99,957
-63% -$6.72M 0.01% 1188
2025
Q3 		$7.79M Sell
159,905
-36,456
-19% -$2.26M 0.03% 664
2025
Q2 		$14.7M Buy
196,361
+124,230
+172% +$8.23M 0.06% 358
2025
Q1 		$4.58M Buy
+72,131
New +$4.91M 0.02% 843
2024
Q4 		– Sell
-2,565
Closed -$206K – 5119
2024
Q3 		$206K Sell
2,565
-2,467
-49% -$199K ﹤0.01% 3987
2024
Q2 		$416K Buy
+5,032
New +$443K ﹤0.01% 3660
2023
Q4 		– Sell
-2,257
Closed -$202K – 5174
2023
Q3 		$202K Buy
+2,257
New +$202K ﹤0.01% 3550
2022
Q2 		– Sell
-4,111
Closed -$260K – 2509
2022
Q1 		$260K Sell
4,111
-3,273
-44% -$178K 0.01% 1389
2021
Q4 		$392K Sell
7,384
-3,037
-29% -$185K 0.01% 1111
2021
Q3 		$736K Buy
+10,421
New +$658K 0.02% 595
2020
Q4 		– Sell
-4,349
Closed -$379K – 1002
2020
Q3 		$379K Buy
+4,349
New +$380K 0.04% 449
2019
Q2 		– Sell
-690
Closed -$60K – 1853
2019
Q1 		$60K Buy
+690
New +$62.8K 0.01% 1172

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Capital's HAE Position: Q2 2026 in Review

Walleye Capital sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 66,359 shares — an estimated $3.74M sold.

Walleye Capital first reported a position in HAE in Q1 2019 and held it in 13 quarters. The position peaked at $14.7M in Q2 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Walleye Capital reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 66,359 Haemonetics shares in Q2 2026, an estimated $3.74M.
  • Walleye Capital first reported a position in Haemonetics in Q1 2019 and held it in 13 quarters.
  • Walleye Capital's Haemonetics position peaked at $14.7M in Q2 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.